MedTrace Logo

Optimizing Bronchopulmonary Cancer Screening

NCT06439901 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-02-03

No results posted yet for this study

Summary

The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.

Conditions

  • Bronchopulmonary Disease
  • Diagnoses Disease

Interventions

OTHER

Screening

A first step to identify and recruit people eligible for screening,

OTHER

Inclusion

A second step for inclusion of participants, with an online self-questionnaire and information, and an inclusion visit to the health center,

OTHER

Chest CTscan and follow-up

A third step with an initial CTscan, with dual interpretation and appropriate management of participants, including follow-up care.

Sponsors & Collaborators

  • Institut Mutualiste Montsouris

    collaborator OTHER

  • Institut Curie

    lead OTHER

Principal Investigators

  • Catherine DANIEL, MD · Institut Curie

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-17
Primary Completion
2032-01-17
Completion
2033-01-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06439901 on ClinicalTrials.gov